Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles

References

• Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14:1310–1316. doi:10.1158/1078-0432.CCR-07-144118316549
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nano. 2007;2:751–760. doi:10.1038/nnano.2007.387
   PubMed Web of Science ®Google Scholar
• Mo R, Jiang T, Gu Z. Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery. Angew Int Ed Chemie. 2014;53:1–7. doi:10.1002/anie.201400268
   Web of Science ®Google Scholar
• Dicheva BM, Ten Hagen TLM, Seynhaeve ALB, Amin M, Eggermont AMM, Koning GA. Enhanced specificity and drug delivery in tumors by cRGD - anchoring thermosensitive liposomes. Pharm Res. 2015;32(12):3862. doi:10.1007/s11095-014-1538-526202516
   PubMedGoogle Scholar
• Talelli M, Barz M, Rijcken CJF, Kiessling F, Hennink WE, Lammers T. Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation. Nano Today. 2015;10(1):93–117. doi:10.1016/j.nantod.2015.01.00525893004
   PubMed Web of Science ®Google Scholar
• Jhaveri AM, Vladimir P. Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol. 2014;5:1–26. doi:10.3389/fphar.2014.0000124478702
   PubMedGoogle Scholar
• Wu H, Shi H, Zhang H, et al. Biomaterials Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery. Biomaterials. 2014;35:5369–5380. doi:10.1016/j.biomaterials.2014.03.03824709520
   PubMed Web of Science ®Google Scholar
• Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem. 1996;7(6):703–714. doi:10.1021/bc96006308950489
   PubMed Web of Science ®Google Scholar
• Zhang C, Pan D, Luo K, She W, Guo C, Yang Y. Peptide dendrimer – doxorubicin conjugate-based nanoparticle as an enzyme-responsive drug delivery system for cancer therapy. Adv Healthc Mater. 2014;3(8):1299–1308.24706635
   PubMed Web of Science ®Google Scholar
• Yavuz B, Pehlivan SB, Imran Vural NÜ. In vitro/In vivo evaluation of dexamethasone-PAMAM dendrimer complexes for retinal drug delivery. Pharm Drug Deliv Pharm Technol. 2015;104:3814–3823.
   Google Scholar
• Maleki Dizaj S, Barzegar-Jalali M, Hossein Zarrintan M, Adibkia K, Lotfipour F. Calcium carbonate nanoparticles as cancer drug delivery system. Expert Opin Drug Deliv. 2015;12(10):1649–1660. doi:10.1517/17425247.2015.104953026005036
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang W, Hong C, Pan C. Silica nanotubes decorated by pH-responsive diblock copolymers for controlled drug release. ACS Appl Mater Interfaces. 2015;7(6):3618–3625. doi:10.1021/am507832n25625307
   PubMedGoogle Scholar
• Vallet-Regí M, Colilla M, Izquierdo-Barba I, Manzano M. Mesoporous silica nanoparticles for drug delivery: current insights. Molecules. 2018;23(1):47. doi:10.3390/molecules23010047
   Web of Science ®Google Scholar
• Poonia N, Lather V, Pandita D. Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer. Drug Discov Today. 2017;23(2):315–332. doi:10.1016/j.drudis.2017.10.02229128658
   PubMed Web of Science ®Google Scholar
• Petrak K. Essential properties of drug-targeting delivery systems. Drug Discov Today. 2005;10(23):1667–1673. doi:10.1016/S1359-6446(05)03698-616376827
   PubMedGoogle Scholar
• Vogt C, Toprak MS, Muhammed M, Laurent S, Jean-Luc Bridot RNM. High quality and tuneable silica shell-magnetic core nanoparticles. J Nanopart Res. 2010;12(4):1137–1147. doi:10.1007/s11051-009-9661-7
   Web of Science ®Google Scholar
• Slowing II, Trewyn BG, Lin VS. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. Jacs. 2007;129:8845–8849. doi:10.1021/ja0719780
   PubMed Web of Science ®Google Scholar
• Bharti C, Nagaich U, Pal AK, Gulati N. Mesoporous silica nanoparticles in target drug delivery system: a review. Int J Pharm Investig. 2015;5(3):124–133. doi:10.4103/2230-973X.160844
   PubMed Web of Science ®Google Scholar
• Khosravian P, Ardestani MS, Khoobi M, et al. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel. Onco Targets Ther. 2016;9:7315–7330. doi:10.2147/OTT.S11381527980423
   PubMed Web of Science ®Google Scholar
• Meng H, Wang M, Liu H, et al. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano. 2015;9(4):3540–3557. doi:10.1021/acsnano.5b0051025776964
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Sahlgren C, Lindén M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr Drugs Targets. 2011;12:1166–1186. doi:10.2174/138945011795906624
   PubMed Web of Science ®Google Scholar
• Napierska D, Thomassen LCJ, Rabolli V, et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small. 2009;5(7):846–853. doi:10.1002/smll.20080046119288475
   PubMed Web of Science ®Google Scholar
• Lu F, Wu S, Hung Y, Mou C. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small. 2009;5(12):1408–1413. doi:10.1002/smll.v5:1219296554
   PubMed Web of Science ®Google Scholar
• Oh W, Kim S, Choi M, et al. Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. ACS Nano. 2010;4(9):5301–5313. doi:10.1021/nn100561e20698555
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S, Lhj DH, Evers NM, et al. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol. 2010;7(25):1–12. doi:10.1186/1743-8977-7-120180970
   PubMedGoogle Scholar
• Dávila-Ibáñez AB, Salgueirino V, Martinez-Zorzano V, et al. Magnetic silica nanoparticle cellular uptake and cytotoxicity regulated by electrostatic polyelectrolytes-DNA loading at their surface. ACS Nano. 2012;1:747–759. doi:10.1021/nn204231g
   Google Scholar
• Dávila-Ibáñez AB, Buurma NJ, Salgueriño V. Assessment of DNA complexation onto polyelectrolyte-coated magnetic silica nanoparticles. Nanoscale. 2013;5:4797–4807. doi:10.1039/c3nr34358h23612682
   PubMedGoogle Scholar
• Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM, Le L. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat. 2002;200:581–597.12162726
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653–664. doi:10.1038/nrclinonc.2010.13920838415
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25. doi:10.1016/j.addr.2013.11.00924270007
   PubMed Web of Science ®Google Scholar
• Noguchi Y, Wu J, Duncan R, Ulbrich K, Akaike T. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res. 1998;89:307–314.9600125
   PubMedGoogle Scholar
• Lee JE, Lee N, Kim H, et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. Jacs. 2010;132:552–557. doi:10.1021/ja905793q
   PubMed Web of Science ®Google Scholar
• Meng H, Mai WX, Zhang H, et al. Codelivery of an optimal Drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano. 2013;7(2):994–1005. doi:10.1021/nn304406623289892
   PubMed Web of Science ®Google Scholar
• Durfee PN, Lin Y, Dunphy DR, et al. Mesoporous silica nanoparticle-supported lipid bilayers (Protocells) for active targeting and delivery to individual leukemia cells. ACS Nano. 2016;10(9):8325–8345. doi:10.1021/acsnano.6b0281927419663
   PubMed Web of Science ®Google Scholar
• Babaei M, Abnous K, Taghdisi SM, et al. Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma. Nanomedicine. 2017;12(11):1261–1279. doi:10.2217/nnm-2017-002828520529
   PubMed Web of Science ®Google Scholar
• Zhou S, Wu D, Yin X, et al. Intracellular pH-responsive and rituximab- conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells. J Exp Clin Cancer Res. 2017;36(24):1–14. doi:10.1186/s13046-016-0473-128049532
   PubMedGoogle Scholar
• Li M, Zhang W, Wang B, Gao Y, Song Z, Zheng QC. Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma. Int J Nanomedicine. 2016;1:5645–5669. doi:10.2147/IJN.S115727
   Google Scholar
• Wang K, Yao H, Meng Y, Wang Y, Yan X, Huang R. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy. Acta Biomater. 2015;16:196–205. doi:10.1016/j.actbio.2015.01.00225596325
   PubMed Web of Science ®Google Scholar
• Mo J, He L, Ma B, Chen T. Tailoring particle size of mesoporous silica nanosystem to antagonize glioblastoma and overcome blood-brain barrier. ACS Appl Mater Interfaces. 2016;8(11):6811–6825. doi:10.1021/acsami.5b1173026911360
   PubMed Web of Science ®Google Scholar
• Slowing II, Vivero-Escoto JL, Wu C, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60:1278–1288. doi:10.1016/j.addr.2008.03.01218514969
   PubMed Web of Science ®Google Scholar
• Warburg O, Franz Wind AEN. The metabolism of tumors in the body. J Gen Physiol. 1926;8:519–530. doi:10.1085/jgp.8.6.519
   Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314.13298683
   PubMed Web of Science ®Google Scholar
• Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science (80-). 1997;277:1232–1237. doi:10.1126/science.277.5330.1232
   Web of Science ®Google Scholar
• Sukhorukov GB, Donath E, Lichtenfeld H, et al. Layer-by-layer self assembly of polyelectrolytes on colloidal particles. Colloids Surf A. 1998;137:253–266. doi:10.1016/S0927-7757(98)00213-1
   Web of Science ®Google Scholar
• Donath E, Sukhorukov GB, Caruso F, Davis SA, Möhwald H. Novel hollow polymer shells by colloid-templated assembly of polyelectrolytes. Angew Int Ed Chemie. 1998;37(16):2201–2205. doi:10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Feng W, Nie W, He C, et al. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. ACS Appl Mater Interfaces. 2014;6(11):8447–8460. doi:10.1021/am501337s24745551
   PubMed Web of Science ®Google Scholar
• Xu R, Sun G, Li Q, Wang E, Gu J. A dual-responsive superparamagnetic Fe3O4/Silica/PAH/PSS material used for controlled release of chemotherapeutic agent, keggin polyoxotungstate, PM −19. Solid State Sci. 2010;12(10):1720–1725. doi:10.1016/j.solidstatesciences.2010.06.026
   Web of Science ®Google Scholar
• Feng W, Zhou X, He C, et al. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility. J Mater Chem B. 2013;1:5886–5898. doi:10.1039/c3tb21193b
   PubMed Web of Science ®Google Scholar
• Wan X, Zhang G, Liu S. pH-disintegrable polyelectrolyte multilayer- coated mesoporous silica nanoparticles exhibiting triggered co-release of cisplatin and model drug molecules. Macromol Rapid Commun. 2011;32(14):1082–1089. doi:10.1002/marc.20110019821618323
   PubMedGoogle Scholar
• Chen T, Hao Y, Yang N, Wang M, Dinga C, Fu J. Graphene quantum dot-capped mesoporous silica nanoparticles through an acid-cleavable acetal bond for intracellular drug delivery and imaging. Mater Chem B. 2014;2:4979–4982. doi:10.1039/C4TB00849A
   PubMed Web of Science ®Google Scholar
• Chen Y, Ai K, Liu J, Sun G, Yin Q, Lu L. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. Biomaterials. 2015;60:111–120. doi:10.1016/j.biomaterials.2015.05.00325988726
   PubMed Web of Science ®Google Scholar
• Martínez-Carmona M, Lozano D, Vallet-Regí M. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Acta Biomater. 2018;65:393–404. doi:10.1016/j.actbio.2017.11.00729127069
   PubMed Web of Science ®Google Scholar
• Chem JM, Cheng S, Liao W, Chen L, Lee C. pH-controllable release using functionalized mesoporous silica nanoparticles as an oral drug delivery system. J Mater Chem. 2011;21:7130–7137. doi:10.1039/c0jm04490c
   Web of Science ®Google Scholar
• Huang I, Sun S, Cheng S, Lee C, Wu C. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance. Ther Discov. 2011;10(5):761–769.
   Google Scholar
• Lin C, Cheng S, Liao W, et al. Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin. Int J Pharm. 2012;429:138–147. doi:10.1016/j.ijpharm.2012.03.02622465413
   PubMed Web of Science ®Google Scholar
• Lin J, Du J, Yang Y, Li L, Zhang D. pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery. Mater Sci Eng C Mater Biol Appl. 2017;81:478–484. doi:10.1016/j.msec.2017.08.03628888000
   PubMed Web of Science ®Google Scholar
• Zhang M, Jia L, Ying K, et al. Ingenious pH-sensitive dextran/mesoporous silica nanoparticles based drug delivery systems for controlled intracellular drug release. Int J Biol Macromol. 2017;98:691–700. doi:10.1016/j.ijbiomac.2017.01.13628174081
   PubMed Web of Science ®Google Scholar
• Sun L, Zhang X, An J, Su C, Guo Q, Li C. Boronate ester bond-based core–shell nanocarriers with pH response for anticancer drug delivery. RSC Adv. 2014;4:20208–20215. doi:10.1039/C4RA01812E
   Web of Science ®Google Scholar
• Tan L, Yang M, Wu H, et al. Glucose- and pH-responsive nanogated ensemble based on polymeric network capped mesoporous silica. ACS Appl Mater Interfaces. 2015;7:6310−6316. doi:10.1021/acsami.5b0063125735191
   PubMed Web of Science ®Google Scholar
• Li Z, Liu Y, Wang X, et al. One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma. ACS Appl Mater Interfaces. 2013;5:7995−8001. doi:10.1021/am401486h23869943
   PubMed Web of Science ®Google Scholar
• Lee C, Cheng S, Huang I, et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Int Ed Chemie. 2010;49:8214–8219. doi:10.1002/anie.201002639
   PubMed Web of Science ®Google Scholar
• Cheng Y, Luo G, Zhu J, et al. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. ACS Appl Mater Interfaces. 2015;7:9078−9087. doi:10.1021/acsami.5b0075225893819
   PubMed Web of Science ®Google Scholar
• De la Rica R, Aili D, Stevens MM. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv Drug Deliv Rev. 2012;64(11):967–978. doi:10.1016/j.addr.2012.01.00222266127
   PubMed Web of Science ®Google Scholar
• Liu Y, Ding X, Li J, et al. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo. Nanotechnology. 2015;26(14):145102. doi:10.1088/0957-4484/26/14/14510225789511
   PubMed Web of Science ®Google Scholar
• Saito G, Swanson JA, Lee K. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: rola and site of cellular reducing activities. Adv Drug Deliv Rev. 2003;55:199–215.12564977
   PubMed Web of Science ®Google Scholar
• Chen X, Sun H, Hu J, Han X, Liu H, Hu Y. Biointerfaces Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery. Colloids Surf B Biointerfaces. 2017;152:77–84. doi:10.1016/j.colsurfb.2017.01.01028088015
   PubMed Web of Science ®Google Scholar
• Mortera R, Vivero-Escoto J, Slowing II, Garrone E, Onida B, Lin VS. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. Chem Commun. 2009;(22):3219–3221. doi:10.1039/b900559e
   PubMed Web of Science ®Google Scholar
• Ma X, Nguyen KT, Borah P, Ang CY, Zhao Y. Functional silica nanoparticles for redox-triggered Drug/ssDNA co-delivery. Adv Healthc Mater. 2012;1(6):690–697. doi:10.1002/adhm.20120012323184818
   PubMedGoogle Scholar
• Nadrah P, Porta F, Planinsek O, Krosb A, Gabersek M. Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better. Phys Chem Chem Phys. 2013;15:10740–10748. doi:10.1039/c3cp44614j23689395
   PubMed Web of Science ®Google Scholar
• Zhang J, Niemelä M, Westermarck J, Rosenholm JM. Mesoporous silica nanoparticles with redoxresponsive surface linkers for charge-reversible loading and release of short oligonucleotide. Dalt Trans. 2014;43:4115–4126. doi:10.1039/c3dt53071j
   PubMed Web of Science ®Google Scholar
• Torney F, Trewyn BG, Lin VS-Y, Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol. 2007;2:295–300. doi:10.1038/nnano.2007.10818654287
   PubMed Web of Science ®Google Scholar
• Giri S, Trewyn BG, Stellmaker MP, Lin VS-Y. Stimuli-Responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem. 2005;117:5166–5172. doi:10.1002/ange.200501819
   Google Scholar
• Yi Z, Hussain HI, Feng C, et al. Functionalized mesoporous silica nanoparticles with redox- responsive short-chain gatekeepers for agrochemical delivery. ACS Appl Mater Interfaces. 2015;7(18):9937–9946. doi:10.1021/acsami.5b0213125902154
   PubMed Web of Science ®Google Scholar
• Gong H, Xie Z, Liu M, Zhu H, Sun H. Redox-sensitive mesoporous silica nanoparticles functionalized with PEG through a disulfide bond linker for potential anticancer drug delivery. RSC Adv. 2015;5:59576–59582. doi:10.1039/C5RA09774F
   Web of Science ®Google Scholar
• Palanikumar L, Choi ES, Cheon JY, Joo SH, Ryu J-H. Noncovalent polymer-gatekeeper in mesoporous silica nanoparticles as a targeted drug delivery platform. Adv Funct Mater. 2014;25(6):957–965. doi:10.1002/adfm.201402755
   Web of Science ®Google Scholar
• Gimenez C, De La Torre C, Gorbe M, et al. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells. Langmuir. 2015;31(12):3753–3762. doi:10.1021/acs.langmuir.5b0013925742160
   PubMed Web of Science ®Google Scholar
• Liu R, Zhao X, Wu T, Feng P. Tunable redox-responsive hybrid nanogated ensembles. Jacs. 2008;130:14418–14419. doi:10.1021/ja8060886
   PubMed Web of Science ®Google Scholar
• Watermann A, Brieger J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials. 2017;7(7):189. doi:10.3390/nano7120458
   Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Publ Gr. 2013;12(11):991–1003.
   Google Scholar
• Laurent S, Dutz S, Häfeli UO, Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 2011;166(1–2):8–23. doi:10.1016/j.cis.2011.04.00321601820
   PubMed Web of Science ®Google Scholar
• Torres-Lugo M, Rinaldi C. Thermal potentiation of chemotherapy by magnetic nanoparticles. Nanomedicine. 2013;8(10):1689–1707. doi:10.2217/nnm.13.14624074390
   PubMed Web of Science ®Google Scholar
• Guisasola E, Baeza A, Talelli M, et al. Magnetic-responsive release controlled by hot spot effect. Langmuir. 2015;31(46):12777–12782. doi:10.1021/acs.langmuir.5b0347026536300
   PubMedGoogle Scholar
• Baeza A, Guisasola E, Ruiz-Herna E, Vallet-Regí M. Magnetically triggered multidrug release by hybrid mesoporous silica nanoparticles. Chem Mater. 2012;24:517−524. doi:10.1021/cm203000u
   Web of Science ®Google Scholar
• Thomas CR, Ferris DP, Lee J, et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. Jacs. 2010;132:10623–10625. doi:10.1021/ja1022267
   PubMed Web of Science ®Google Scholar
• Ferris DP, Zhao Y, Khashab NM, Khatib HA, Stoddart JF, Zink JI. Light-operated mechanized nanoparticles. Jacs. 2009;131:1686–1688.
   PubMed Web of Science ®Google Scholar
• Wu S, Butt H-J. Near-infrared-sensitive materials based on upconverting nanoparticles. Adv Mater. 2016;28:1208–1226.26389516
   PubMed Web of Science ®Google Scholar
• Inoue Y, Kuad P, Okumura Y, Takashima Y, Yamaguchi H, Harada A. Thermal and photochemical switching of conformation of Poly(ethylene glycol)-substituted cyclodextrin with an azobenzene group at the chain end. Jacs. 2007;129:6396–6397.
   PubMed Web of Science ®Google Scholar
• Wang Z, Johns VK, Liao Y. Controlled release of fragrant molecules with visible light. Chem Eur J. 2014;20:1–5.
   Web of Science ®Google Scholar
• Mekaru JLH, Tamanoi F. Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv Drug Deliv Rev. 2015;95:40–49.26434537
   PubMed Web of Science ®Google Scholar
• Guardado-Álvarez TM, Devi LS, Russell MM, Schwartz BJ, Zink JI. Activation of snap-top capped mesoporous silica nanocontainers using two near-infrared photons. Jacs. 2013;135(38):14000–14003.
   PubMed Web of Science ®Google Scholar
• Martínez-Carmona M, Lozano D, Baeza A, Colillaa M, Vallet-Regí M. A novel visible light responsive nanosystem for cancer treatment. Nanoscale. 2017;9(41):15967–15973.29019495
   PubMed Web of Science ®Google Scholar
• Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev. 2011;62(11):1064–1079.
   Web of Science ®Google Scholar
• Tong L, Wei Q, Wei A, Cheng J. Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochem Photobiol. 2009;85:21–32.19161395
   PubMed Web of Science ®Google Scholar
• Ke H, Wang J, Dai Z, et al. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Int Ed Chemie. 2011;50:3017–3021.
   PubMed Web of Science ®Google Scholar
• Wang X, Tan -L-L, Li X, et al. Smart mesoporous silica nanoparticles gated by pillararene-modified gold nanoparticles for on-demand cargo release. Chem Commun. 2016;52:13775–13778.
   PubMed Web of Science ®Google Scholar
• Vivero-Escoto JL, Slowing II, Wu C-W, Lin VS-Y. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. Jacs. 2009;131:3462–3463.
   PubMed Web of Science ®Google Scholar
• Suit HD, Gerweck LE. Potential for hyperthermia and radiation therapy. Cancer Res. 1979;39:2290–2298.36224
   PubMed Web of Science ®Google Scholar
• Deswal K, Chohan IS. Effects of hyperthermia on enzymes and electrolytes in blood and cerebrospinal fluid in dogs. Int J Biometeor. 1981;25(3):227–233.
   PubMed Web of Science ®Google Scholar
• González-Domíngez E, Iturrioz-Rodríguez N, Padín-González E, et al. Carbon nanotubes gathered onto silica particles lose their biomimetic properties with the cytoskeleton becoming biocompatible. Int J Nanomed. 2017;12:6317–6328.
   PubMed Web of Science ®Google Scholar
• Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine. 2014;9:51–63. doi:10.2147/IJN.S2659224872703
   PubMed Web of Science ®Google Scholar
• Hu L, Mao Z, Zhang Y, Gao C. Influences of size of silica particles on the cellular endocytosis, exocytosis and cell activity of HepG2 cells. J Nanosci Lett. 2011;1(1):1–16.
   Google Scholar
• Freeman EC, Weiland LM, Meng WS. Modeling the proton sponge hypothesis: examining proton sponge effectiveness for enhancing intracellular gene delivery through multiescale modeling. J Biomater Sci Poly Ed. 2014;24(4):398–416. doi:10.1080/09205063.2012.690282
   Web of Science ®Google Scholar
• Iturrioz-Rodriguez N, González-Lavado E, Marín- L, Araújo BV, Pérez-Lorenzo M, Fanarraga ML. A biomimetic escape strategy for cytoplasm invasion by synthetic particles. Angew Int Ed Chemie. 2017;56(44):13736–13740. doi:10.1002/anie.201707769
   PubMed Web of Science ®Google Scholar
• Nelson N. Structure and pharmacology of the proton-ATPases. Trends Pharmacol Sci. 1991;12:71–75.1827218
   PubMed Web of Science ®Google Scholar
• Wu M, Meng Q, Chen Y, et al. Large pore-sized hollow mesoporous organosilica for redox-responsive gene delivery and synergistic cancer chemotherapy. Adv Mater. 2016;28:1963–1969. doi:10.1002/adma.20150552426743228
   PubMed Web of Science ®Google Scholar
• Shen J, Kim H, Su H, et al. Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics. 2014;4:487–497. doi:10.7150/thno.826324672582
   PubMed Web of Science ®Google Scholar
• Ma D. Enhancing endosomal escape for nanoparticle mediated siRNA delivery. Nanoscale. 2014;6:6415–6425. doi:10.1039/c4nr00018h24837409
   PubMed Web of Science ®Google Scholar
• Zhang X, Li F, Guo S, et al. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells. Biomaterials. 2014;35(11):3650–3665. doi:10.1016/j.biomaterials.2014.01.01324462359
   PubMedGoogle Scholar
• Crombez L, Charnet A, Morris MC, Aldrian-Herrada G, Heitz F, Divita G. A non-covalent peptide-based strategy for siRNA delivery. Biochem Soc Trans. 2007;35:44–46. doi:10.1042/BST035004417233597
   PubMed Web of Science ®Google Scholar
• Nakase I, Akita H, Kogure K, et al. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Acc Chem Res. 2012;45(7):1132–1139. doi:10.1021/ar200256e22208383
   PubMed Web of Science ®Google Scholar
• Li X, Chen Y, Wang M, Ma Y, Xia W, Gu H. A mesoporous silica nanoparticle e PEI e Fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials. 2013;34:1391–1401. doi:10.1016/j.biomaterials.2012.10.07223164421
   PubMed Web of Science ®Google Scholar
• Agostini A, Mondragón L, Bernardos A, et al. Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles. Angew Int Ed Chemie. 2012;51:1–6. doi:10.1002/anie.201204663
   Web of Science ®Google Scholar
• Chen Y, Chen H, Shi J. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv Mater. 2013;25:1–33. doi:10.1002/adma.201205292
   Web of Science ®Google Scholar
• Shi Y, Hélary C, Haye B, Coradin T. Extracellular versus Intracellular Degradation of Nanostructured Silica Particles. Langmuir. 2018;34:406–415. doi:10.1021/acs.langmuir.7b0223129224358
   PubMed Web of Science ®Google Scholar
• Chen D, Hao N, Liu H, et al. In vitro degradation behavior of silica nanoparticles under physiological conditions in vitro degradation behavior of silica nanoparticles under physiological conditions. J Nanosci Nanotechnol. 2012;12:6346–6354.22962747
   PubMed Web of Science ®Google Scholar
• Huang X, Young NP, Townley HE. Characterization and comparison of mesoporous silica particles for optimized drug delivery. Nanomater Nanotechnol. 2014;4(2):1–15. doi:10.5772/58290
   Google Scholar
• Paris JL, Cabañas MV, Manzano M, Vallet-Regí M. Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers. ACS Nano. 2015;9(11):11023–11033. doi:10.1021/acsnano.5b0437826456489
   PubMed Web of Science ®Google Scholar
• Cauda V, Argyo C, Bein T. Impact of different PEGylation patterns on the long-term bio-stability of colloidal mesoporous silica nanoparticles. J Mater Chem. 2010;20:8693–8699. doi:10.1039/c0jm01390k
   Web of Science ®Google Scholar
• Yamada H, Urata C, Aoyama Y, Osada S, Yamauchi Y, Kuroda K. Preparation of colloidal mesoporous silica nanoparticles with different diameters and their unique degradation behavior in static aqueous systems. Chem Mater. 2012;24:1462−1471. doi:10.1021/cm3001688
   Web of Science ®Google Scholar
• Braun K, Pochert A, Beck M, Fiedler R. Dissolution kinetics of mesoporous silica nanoparticles in different simulated body fluids. J Sol-Gel Sci Technol. 2016;79(2):319–327. doi:10.1007/s10971-016-4053-9
   Web of Science ®Google Scholar
• Roggers RA, Joglekar M, Valenstein JS, Trewyn BG. Mimicking red blood cell lipid membrane to enhance the hemocompatibility of large-pore mesoporous silica. ACS Appl Mater Interfaces. 2014;6(3):1675–1681. doi:10.1021/am404571324417657
   PubMedGoogle Scholar
• Lu J, Li Z, Zink JI, Tamanoi F. In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification. Nanomedicine NBM. 2012;8(2):212–220. doi:10.1016/j.nano.2011.06.002
   PubMed Web of Science ®Google Scholar
• He Q, Zhang Z, Gao F, Li Y, Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and pegylation. Small. 2011;7(2):271–280. doi:10.1002/smll.20100145921213393
   PubMed Web of Science ®Google Scholar